TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
SMP00618	Fosphenytoin (Antiarrhythmic) Metabolism Pathway	0.00362818557866812	-5.61902259625462	4	3	0.0306122448979592	98	978	6640,6331,6641	SNTA1,SCN5A,SNTB1
SMP00499	Beta-mercaptolactate-cysteine disulfiduria	0.00805721641603819	-4.82118713992498	9	4	0.0408163265306122	98	978	2805,2730,2729,1491	GOT1,GCLM,GCLC,CTH
SMP00013	Cysteine Metabolism	0.00805721641603819	-4.82118713992498	9	4	0.0408163265306122	98	978	2805,2730,2729,1491	GOT1,GCLM,GCLC,CTH
SMP00722	Cystinosis- ocular nonnephropathic	0.00805721641603819	-4.82118713992498	9	4	0.0408163265306122	98	978	2730,2805,2729,1491	GCLM,GOT1,GCLC,CTH
SMP00582	Joubert syndrome	0.0135547867326529	-4.30101552963718	21	6	0.0612244897959184	98	978	2064,5293,200576,5295,8821,5290	ERBB2,PIK3CD,PIKFYVE,PIK3R1,INPP4B,PIK3CA
SMP00433	Irinotecan Action Pathway	0.0135547867326529	-4.30101552963718	21	6	0.0612244897959184	98	978	51726,10130,10961,5243,9601,9429	DNAJB11,PDIA6,ERP29,ABCB1,PDIA4,ABCG2
SMP00600	Irinotecan Metabolism Pathway	0.0135547867326529	-4.30101552963718	21	6	0.0612244897959184	98	978	51726,10130,10961,5243,9601,9429	DNAJB11,PDIA6,ERP29,ABCB1,PDIA4,ABCG2
SMP00463	Phosphatidylinositol Phosphate Metabolism	0.0135547867326529	-4.30101552963718	21	6	0.0612244897959184	98	978	2064,5293,200576,5295,8821,5290	ERBB2,PIK3CD,PIKFYVE,PIK3R1,INPP4B,PIK3CA
SMP00640	Acetaminophen Metabolism Pathway	0.0165619288193444	-4.10064866220957	28	7	0.0714285714285714	98	978	51726,10130,2950,10961,5243,9601,9429	DNAJB11,PDIA6,GSTP1,ERP29,ABCB1,PDIA4,ABCG2
SMP00442	Etoposide Action Pathway	0.0271288008134546	-3.6071593547827	18	5	0.0510204081632653	98	978	51726,10130,10961,5243,9601	DNAJB11,PDIA6,ERP29,ABCB1,PDIA4
SMP00601	Etoposide Metabolism Pathway	0.0271288008134546	-3.6071593547827	18	5	0.0510204081632653	98	978	51726,10130,10961,5243,9601	DNAJB11,PDIA6,ERP29,ABCB1,PDIA4
SMP00472	Erlotinib Action Pathway	0.027888853877483	-3.57952817257641	3	2	0.0204081632653061	98	978	5243,9429	ABCB1,ABCG2
SMP00320	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	0.0293255478819009	-3.52929620151735	38	8	0.0816326530612245	98	978	2778,207,9693,6195,4792,5290,5600,2002	GNAS,AKT1,RAPGEF2,RPS6KA1,NFKBIA,PIK3CA,MAPK11,ELK1
SMP00321	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	0.0293255478819009	-3.52929620151735	38	8	0.0816326530612245	98	978	2778,207,9693,6195,4792,5290,5600,2002	GNAS,AKT1,RAPGEF2,RPS6KA1,NFKBIA,PIK3CA,MAPK11,ELK1
SMP00037	Lysine Degradation	0.0333612541171213	-3.40036010875932	13	4	0.0408163265306122	98	978	55526,501,6542,10157	DHTKD1,ALDH7A1,SLC7A2,AASS
SMP00186	Glutaric Aciduria Type I	0.0333612541171213	-3.40036010875932	13	4	0.0408163265306122	98	978	55526,501,6542,10157	DHTKD1,ALDH7A1,SLC7A2,AASS
SMP00528	Hyperlysinemia II or Saccharopinuria	0.0333612541171213	-3.40036010875932	13	4	0.0408163265306122	98	978	55526,501,6542,10157	DHTKD1,ALDH7A1,SLC7A2,AASS
SMP00527	Hyperlysinemia I- Familial	0.0333612541171213	-3.40036010875932	13	4	0.0408163265306122	98	978	55526,501,6542,10157	DHTKD1,ALDH7A1,SLC7A2,AASS
SMP00239	Saccharopinuria/Hyperlysinemia II	0.0333612541171213	-3.40036010875932	13	4	0.0408163265306122	98	978	55526,501,6542,10157	DHTKD1,ALDH7A1,SLC7A2,AASS
SMP00719	2-aminoadipic 2-oxoadipic aciduria	0.0333612541171213	-3.40036010875932	13	4	0.0408163265306122	98	978	55526,501,6542,10157	DHTKD1,ALDH7A1,SLC7A2,AASS
SMP00571	Pyridoxine dependency with seizures	0.0333612541171213	-3.40036010875932	13	4	0.0408163265306122	98	978	55526,501,6542,10157	DHTKD1,ALDH7A1,SLC7A2,AASS
SMP00327	Phenytoin (Antiarrhythmic) Action Pathway	0.0355279777118561	-3.33743478833277	77	13	0.13265306122449	98	978	6640,6331,476,1728,801,9254,51726,481,6641,10961,5566,10130,9601	SNTA1,SCN5A,ATP1A1,NQO1,CALM1,CACNA2D2,DNAJB11,ATP1B1,SNTB1,ERP29,PRKACA,PDIA6,PDIA4
SMP00406	Morphine Action Pathway	0.0389447907535588	-3.24561025749515	40	8	0.0816326530612245	98	978	476,2902,9254,51726,481,10961,10130,9601	ATP1A1,GRIN1,CACNA2D2,DNAJB11,ATP1B1,ERP29,PDIA6,PDIA4
SMP00648	Sorafenib Metabolism Pathway	0.0431956998243395	-3.14201432978987	14	4	0.0408163265306122	98	978	51726,10130,10961,9601	DNAJB11,PDIA6,ERP29,PDIA4
SMP00622	Morphine Metabolism Pathway	0.0544917719400572	-2.90970556228753	15	4	0.0408163265306122	98	978	51726,10130,10961,9601	DNAJB11,PDIA6,ERP29,PDIA4
SMP00469	Capecitabine Action Pathway	0.081308819599116	-2.50950078615819	5	2	0.0204081632653061	98	978	1890,978	TYMP,CDA
SMP00607	Capecitabine Metabolism Pathway	0.081308819599116	-2.50950078615819	5	2	0.0204081632653061	98	978	1890,978	TYMP,CDA
SMP00650	Doxorubicin Metabolism Pathway	0.0813834402974068	-2.50858346281938	17	4	0.0408163265306122	98	978	1728,7498,5243,9429	NQO1,XDH,ABCB1,ABCG2
SMP00015	Glutathione Metabolism	0.0888989454265153	-2.42025499900153	11	3	0.0306122448979592	98	978	26873,2730,2729	OPLAH,GCLM,GCLC
SMP00500	5-oxoprolinase deficiency	0.0888989454265153	-2.42025499900153	11	3	0.0306122448979592	98	978	26873,2730,2729	OPLAH,GCLM,GCLC
SMP00337	Glutathione Synthetase Deficiency	0.0888989454265153	-2.42025499900153	11	3	0.0306122448979592	98	978	26873,2730,2729	OPLAH,GCLM,GCLC
SMP00143	5-Oxoprolinuria	0.0888989454265153	-2.42025499900153	11	3	0.0306122448979592	98	978	26873,2730,2729	OPLAH,GCLM,GCLC
SMP00501	Gamma-glutamyl-transpeptidase deficiency	0.0888989454265153	-2.42025499900153	11	3	0.0306122448979592	98	978	26873,2730,2729	OPLAH,GCLM,GCLC
SMP00029	Selenoamino Acid Metabolism	0.0888989454265153	-2.42025499900153	11	3	0.0306122448979592	98	978	191,9061,1491	AHCY,PAPSS1,CTH
SMP00183	Gamma-Glutamyltransferase Deficiency	0.0888989454265153	-2.42025499900153	11	3	0.0306122448979592	98	978	26873,2730,2729	OPLAH,GCLM,GCLC
SMP00263	Cilostazol Action Pathway	0.100204498977615	-2.30054219136315	1	1	0.0102040816326531	98	978	5144	PDE4D
SMP00264	Dipyridamole (Antiplatelet) Action Pathway	0.100204498977615	-2.30054219136315	1	1	0.0102040816326531	98	978	5144	PDE4D
SMP00027	Pantothenate and CoA Biosynthesis	0.114161727922822	-2.17013916995384	6	2	0.0204081632653061	98	978	5167,53354	ENPP1,PANK1
SMP00363	Ornithine Aminotransferase Deficiency (OAT Deficiency)	0.131638252358911	-2.02769763090738	20	4	0.0408163265306122	98	978	5625,2805,4942,283208	PRODH,GOT1,OAT,P4HA3
SMP00506	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	0.131638252358911	-2.02769763090738	20	4	0.0408163265306122	98	978	5625,2805,4942,283208	PRODH,GOT1,OAT,P4HA3
SMP00507	L-arginine:glycine amidinotransferase deficiency	0.131638252358911	-2.02769763090738	20	4	0.0408163265306122	98	978	5625,2805,4942,283208	PRODH,GOT1,OAT,P4HA3
SMP00505	Hyperornithinemia with gyrate atrophy (HOGA)	0.131638252358911	-2.02769763090738	20	4	0.0408163265306122	98	978	5625,2805,4942,283208	PRODH,GOT1,OAT,P4HA3
SMP00362	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	0.131638252358911	-2.02769763090738	20	4	0.0408163265306122	98	978	5625,2805,4942,283208	PRODH,GOT1,OAT,P4HA3
SMP00504	Creatine deficiency- guanidinoacetate methyltransferase deficiency	0.131638252358911	-2.02769763090738	20	4	0.0408163265306122	98	978	5625,2805,4942,283208	PRODH,GOT1,OAT,P4HA3
SMP00207	Prolidase Deficiency (PD)	0.131638252358911	-2.02769763090738	20	4	0.0408163265306122	98	978	5625,2805,4942,283208	PRODH,GOT1,OAT,P4HA3
SMP00360	Hyperprolinemia Type II	0.131638252358911	-2.02769763090738	20	4	0.0408163265306122	98	978	5625,2805,4942,283208	PRODH,GOT1,OAT,P4HA3
SMP00188	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	0.131638252358911	-2.02769763090738	20	4	0.0408163265306122	98	978	5625,2805,4942,283208	PRODH,GOT1,OAT,P4HA3
SMP00208	Prolinemia Type II	0.131638252358911	-2.02769763090738	20	4	0.0408163265306122	98	978	5625,2805,4942,283208	PRODH,GOT1,OAT,P4HA3
SMP00361	Hyperprolinemia Type I	0.131638252358911	-2.02769763090738	20	4	0.0408163265306122	98	978	5625,2805,4942,283208	PRODH,GOT1,OAT,P4HA3
SMP00020	Arginine and Proline Metabolism	0.131638252358911	-2.02769763090738	20	4	0.0408163265306122	98	978	5625,2805,4942,283208	PRODH,GOT1,OAT,P4HA3
SMP00554	Glycogenosis- Type IV. Amylopectinosis	0.133258518406004	-2.01546428997946	13	3	0.0306122448979592	98	978	283209,5236,2990	PGM2L1,PGM1,GUSB
SMP00043	Galactose Metabolism	0.133258518406004	-2.01546428997946	13	3	0.0306122448979592	98	978	5236,2548,2717	PGM1,GAA,GLA
SMP00553	Glycogenosis- Type III. Cori disease	0.133258518406004	-2.01546428997946	13	3	0.0306122448979592	98	978	283209,5236,2990	PGM2L1,PGM1,GUSB
SMP00182	Galactosemia	0.133258518406004	-2.01546428997946	13	3	0.0306122448979592	98	978	5236,2548,2717	PGM1,GAA,GLA
SMP00434	Paclitaxel Action Pathway	0.149691539887726	-1.89917850292956	7	2	0.0204081632653061	98	978	5243,9429	ABCB1,ABCG2
SMP00682	Leucine Stimulation on Insulin Signaling	0.149691539887726	-1.89917850292956	7	2	0.0204081632653061	98	978	207,6009	AKT1,RHEB
SMP00041	Sulfate/Sulfite Metabolism	0.149691539887726	-1.89917850292956	7	2	0.0204081632653061	98	978	9060,6820	PAPSS2,SULT2B1
SMP00435	Docetaxel Action Pathway	0.149691539887726	-1.89917850292956	7	2	0.0204081632653061	98	978	5243,9429	ABCB1,ABCG2
SMP00532	Sulfite oxidase deficiency	0.149691539887726	-1.89917850292956	7	2	0.0204081632653061	98	978	9060,6820	PAPSS2,SULT2B1
SMP00011	Inositol Metabolism	0.150708536719616	-1.89240752784315	21	4	0.0408163265306122	98	978	51477,3706,200576,5290	ISYNA1,ITPKA,PIKFYVE,PIK3CA
SMP00048	Nicotinate and Nicotinamide Metabolism	0.157821105291971	-1.8462931324163	14	3	0.0306122448979592	98	978	5167,54981,316	ENPP1,NMRK1,AOX1
SMP00044	Histidine Metabolism	0.157821105291971	-1.8462931324163	14	3	0.0306122448979592	98	978	217,144193,3034	ALDH2,AMDHD1,HAL
SMP00191	Histidinemia	0.157821105291971	-1.8462931324163	14	3	0.0306122448979592	98	978	217,144193,3034	ALDH2,AMDHD1,HAL
SMP00462	Inositol Phosphate Metabolism	0.157821105291971	-1.8462931324163	14	3	0.0306122448979592	98	978	51477,3706,8821	ISYNA1,ITPKA,INPP4B
SMP00136	2-Hydroxyglutric Aciduria (D And L Form)	0.170771857482812	-1.76742678003954	22	4	0.0408163265306122	98	978	2673,2730,2571,2729	GFPT1,GCLM,GAD1,GCLC
SMP00567	Succinic semialdehyde dehydrogenase deficiency	0.170771857482812	-1.76742678003954	22	4	0.0408163265306122	98	978	2673,2730,2571,2729	GFPT1,GCLM,GAD1,GCLC
SMP00339	Hyperinsulinism-Hyperammonemia Syndrome	0.170771857482812	-1.76742678003954	22	4	0.0408163265306122	98	978	2673,2730,2571,2729	GFPT1,GCLM,GAD1,GCLC
SMP00243	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	0.170771857482812	-1.76742678003954	22	4	0.0408163265306122	98	978	2673,2730,2571,2729	GFPT1,GCLM,GAD1,GCLC
SMP00590	Ibuprofen Metabolism Pathway	0.170771857482812	-1.76742678003954	22	4	0.0408163265306122	98	978	51726,10130,10961,9601	DNAJB11,PDIA6,ERP29,PDIA4
SMP00385	Homocarnosinosis	0.170771857482812	-1.76742678003954	22	4	0.0408163265306122	98	978	2673,2730,2571,2729	GFPT1,GCLM,GAD1,GCLC
SMP00072	Glutamate Metabolism	0.170771857482812	-1.76742678003954	22	4	0.0408163265306122	98	978	2673,2730,2571,2729	GFPT1,GCLM,GAD1,GCLC
SMP00086	Ibuprofen Action Pathway	0.182242626726303	-1.70241636583192	47	7	0.0714285714285714	98	978	51726,113612,4048,10130,10961,4051,9601	DNAJB11,CYP2U1,LTA4H,PDIA6,ERP29,CYP4F3,PDIA4
SMP00123	Betaine Metabolism	0.187044800836036	-1.67640711415816	8	2	0.0204081632653061	98	978	191,501	AHCY,ALDH7A1
SMP00455	Homocysteine Degradation	0.190460342475139	-1.65831128207053	2	1	0.0102040816326531	98	978	1491	CTH
SMP00515	Homocystinuria- cystathionine beta-synthase deficiency	0.190460342475139	-1.65831128207053	2	1	0.0102040816326531	98	978	1491	CTH
SMP00514	Gamma-cystathionase deficiency (CTH)	0.190460342475139	-1.65831128207053	2	1	0.0102040816326531	98	978	1491	CTH
SMP00306	Pindolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00323	Quinidine Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00660	Sotalol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00379	Nifedipine Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00325	Disopyramide Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00669	Practolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00667	Metipranolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00380	Nimodipine Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00381	Nisoldipine Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00659	Timolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00661	Epinephrine Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00324	Procainamide (Antiarrhythmic) Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00366	Nebivolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00377	Felodipine Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00296	Acebutolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00305	Penbutolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00663	Isoprenaline Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00658	Carteolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00657	Bopindolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00664	Arbutamine Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00588	Muscle/Heart Contraction	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00298	Atenolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00304	Oxprenolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00332	Ibutilide Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00665	Amiodarone Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00378	Isradipine Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00670	Bupranolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00303	Nadolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00297	Alprenolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00331	Flecainide Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00359	Diltiazem Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00375	Verapamil Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00382	Nitrendipine Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00662	Dobutamine Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00329	Mexiletine Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00302	Metoprolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00300	Bisoprolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00376	Amlodipine Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00301	Esmolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00299	Betaxolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00330	Tocainide Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00307	Propranolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00326	Fosphenytoin (Antiarrhythmic) Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00666	Levobunolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00668	Bevantolol Action Pathway	0.202534333514878	-1.5968458585856	57	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00424	Citalopram Action Pathway	0.209937503524588	-1.56094539482088	32	5	0.0510204081632653	98	978	476,481,2902,316,9254	ATP1A1,ATP1B1,GRIN1,AOX1,CACNA2D2
SMP00358	Fc Epsilon Receptor I Signaling in Mast Cells	0.209937503524588	-1.56094539482088	32	5	0.0510204081632653	98	978	5321,207,6850,5295,5290	PLA2G4A,AKT1,SYK,PIK3R1,PIK3CA
SMP00431	Nicotine Action Pathway	0.209937503524588	-1.56094539482088	32	5	0.0510204081632653	98	978	476,481,2902,316,9254	ATP1A1,ATP1B1,GRIN1,AOX1,CACNA2D2
SMP00555	Glycogenosis- Type VI. Hers disease	0.210519560530154	-1.55817670604313	16	3	0.0306122448979592	98	978	283209,5236,2990	PGM2L1,PGM1,GUSB
SMP00058	Starch and Sucrose Metabolism	0.210519560530154	-1.55817670604313	16	3	0.0306122448979592	98	978	283209,5236,2990	PGM2L1,PGM1,GUSB
SMP00557	Sucrase-isomaltase deficiency	0.210519560530154	-1.55817670604313	16	3	0.0306122448979592	98	978	283209,5236,2990	PGM2L1,PGM1,GUSB
SMP00556	Mucopolysaccharidosis VI. Sly syndrome	0.210519560530154	-1.55817670604313	16	3	0.0306122448979592	98	978	283209,5236,2990	PGM2L1,PGM1,GUSB
SMP00552	Glycogen synthetase deficiency	0.210519560530154	-1.55817670604313	16	3	0.0306122448979592	98	978	283209,5236,2990	PGM2L1,PGM1,GUSB
SMP00368	Labetalol Action Pathway	0.216395166721304	-1.53064906718852	58	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00367	Carvedilol Action Pathway	0.216395166721304	-1.53064906718852	58	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00351	GABA-Transaminase Deficiency	0.225509307544562	-1.48939384574902	9	2	0.0204081632653061	98	978	217,2571	ALDH2,GAD1
SMP00492	Ureidopropionase deficiency	0.225509307544562	-1.48939384574902	9	2	0.0204081632653061	98	978	217,2571	ALDH2,GAD1
SMP00493	Carnosinuria- carnosinemia	0.225509307544562	-1.48939384574902	9	2	0.0204081632653061	98	978	217,2571	ALDH2,GAD1
SMP00007	Beta-Alanine Metabolism	0.225509307544562	-1.48939384574902	9	2	0.0204081632653061	98	978	217,2571	ALDH2,GAD1
SMP00328	Lidocaine (Antiarrhythmic) Action Pathway	0.230616405224314	-1.46699953220184	59	8	0.0816326530612245	98	978	6640,6331,476,801,9254,481,6641,5566	SNTA1,SCN5A,ATP1A1,CALM1,CACNA2D2,ATP1B1,SNTB1,PRKACA
SMP00390	Tay-Sachs Disease	0.238191586294303	-1.43467994470701	17	3	0.0306122448979592	98	978	2673,6675,10007	GFPT1,UAP1,GNPDA1
SMP00045	Amino Sugar Metabolism	0.238191586294303	-1.43467994470701	17	3	0.0306122448979592	98	978	2673,6675,10007	GFPT1,UAP1,GNPDA1
SMP00240	Salla Disease/Infantile Sialic Acid Storage Disease	0.238191586294303	-1.43467994470701	17	3	0.0306122448979592	98	978	2673,6675,10007	GFPT1,UAP1,GNPDA1
SMP00534	G(M2)-Gangliosidosis: Variant B- Tay-sachs disease	0.238191586294303	-1.43467994470701	17	3	0.0306122448979592	98	978	2673,6675,10007	GFPT1,UAP1,GNPDA1
SMP00216	Sialuria or French Type Sialuria	0.238191586294303	-1.43467994470701	17	3	0.0306122448979592	98	978	2673,6675,10007	GFPT1,UAP1,GNPDA1
SMP00217	Sialuria or French Type Sialuria	0.238191586294303	-1.43467994470701	17	3	0.0306122448979592	98	978	2673,6675,10007	GFPT1,UAP1,GNPDA1
SMP00674	Anileridine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00411	Hydrocodone Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00689	Dihydromorphine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00687	Naltrexone Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00675	Diphenoxylate Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00417	Sufentanil Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00686	Pentazocine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00404	Ropivacaine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00425	Escitalopram Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00679	3-Methylthiofentanyl Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00681	Ethylmorphine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00684	Buprenorphine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00672	Propoxyphene Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00690	Ketobemidone  Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00392	Benzocaine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00410	Hydromorphone Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00399	Mepivacaine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00678	Methadyl Acetate Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00416	Remifentanil Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00671	Tramadol Action Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00393	Bupivacaine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00396	Dibucaine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00415	Fentanyl Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00673	Levorphanol Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00401	Prilocaine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00685	Alvimopan Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00400	Oxybuprocaine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00394	Chloroprocaine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00414	Carfentanil Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00397	Levobupivacaine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00676	Dezocine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00413	Alfentanil Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00395	Cocaine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00412	Oxymorphone Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00688	Naloxone Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00403	Proparacaine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00677	Levomethadyl Acetate Action Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00683	Levallorphan Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00402	Procaine Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00680	Dimethylthiambutene Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00409	Oxycodone Action Pathway	0.258729768085527	-1.35197112843344	26	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00437	Vincristine Action Pathway	0.264494811828824	-1.32993364289006	10	2	0.0204081632653061	98	978	5243,7157	ABCB1,TP53
SMP00438	Vindesine Action Pathway	0.264494811828824	-1.32993364289006	10	2	0.0204081632653061	98	978	5243,7157	ABCB1,TP53
SMP00649	Lamivudine Metabolism Pathway	0.266452950380663	-1.32255759737641	18	3	0.0306122448979592	98	978	1633,5243,9429	DCK,ABCB1,ABCG2
SMP00619	Felodipine Metabolism Pathway	0.271746086778021	-1.30288715316538	3	1	0.0102040816326531	98	978	9254	CACNA2D2
SMP00464	Vitamin K Metabolism	0.271746086778021	-1.30288715316538	3	1	0.0102040816326531	98	978	1728	NQO1
SMP00691	Nalbuphine Action Pathway	0.282079094481388	-1.26556777048596	27	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00423	Desipramine Action Pathway	0.282079094481388	-1.26556777048596	27	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00063	Tryptophan Metabolism	0.295100700303943	-1.22043862392883	19	3	0.0306122448979592	98	978	217,1543,316	ALDH2,CYP1A1,AOX1
SMP00436	Vinblastine Action Pathway	0.303516115473792	-1.19232057113184	11	2	0.0204081632653061	98	978	5243,7157	ABCB1,TP53
SMP00370	Tyrosinemia Type 3 (TYRO3)	0.303516115473792	-1.19232057113184	11	2	0.0204081632653061	98	978	2805,2184	GOT1,FAH
SMP00008	Phenylalanine and Tyrosine Metabolism	0.303516115473792	-1.19232057113184	11	2	0.0204081632653061	98	978	2805,2184	GOT1,FAH
SMP00439	Vinorelbine Action Pathway	0.303516115473792	-1.19232057113184	11	2	0.0204081632653061	98	978	5243,7157	ABCB1,TP53
SMP00206	Phenylketonuria	0.303516115473792	-1.19232057113184	11	2	0.0204081632653061	98	978	2805,2184	GOT1,FAH
SMP00369	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	0.303516115473792	-1.19232057113184	11	2	0.0204081632653061	98	978	2805,2184	GOT1,FAH
SMP00398	Lidocaine (Local Anaesthetic) Action Pathway	0.305750671044556	-1.1849853096681	28	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00405	Codeine Action Pathway	0.329639527762874	-1.10975556167239	29	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00407	Heroin Action Pathway	0.329639527762874	-1.10975556167239	29	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00458	Lactose Intolerance	0.342178277854702	-1.07242339746199	12	2	0.0204081632653061	98	978	481,476	ATP1B1,ATP1A1
SMP00457	Lactose Degradation	0.342178277854702	-1.07242339746199	12	2	0.0204081632653061	98	978	476,481	ATP1A1,ATP1B1
SMP00450	Phytanic Acid Peroxisomal Oxidation	0.344944941646218	-1.06437046411778	4	1	0.0102040816326531	98	978	224	ALDH3A2
SMP00451	Refsum Disease	0.344944941646218	-1.06437046411778	4	1	0.0102040816326531	98	978	224	ALDH3A2
SMP00525	Fabry disease	0.352820094302319	-1.04179699983224	21	3	0.0306122448979592	98	978	2717,7368,8879	GLA,UGT8,SGPL1
SMP00526	Krabbe disease	0.352820094302319	-1.04179699983224	21	3	0.0306122448979592	98	978	2717,7368,8879	GLA,UGT8,SGPL1
SMP00349	Gaucher Disease	0.352820094302319	-1.04179699983224	21	3	0.0306122448979592	98	978	2717,7368,8879	GLA,UGT8,SGPL1
SMP00034	Sphingolipid Metabolism	0.352820094302319	-1.04179699983224	21	3	0.0306122448979592	98	978	2717,7368,8879	GLA,UGT8,SGPL1
SMP00347	Metachromatic Leukodystrophy (MLD)	0.352820094302319	-1.04179699983224	21	3	0.0306122448979592	98	978	2717,7368,8879	GLA,UGT8,SGPL1
SMP00348	Globoid Cell Leukodystrophy	0.352820094302319	-1.04179699983224	21	3	0.0306122448979592	98	978	2717,7368,8879	GLA,UGT8,SGPL1
SMP00522	3-hydroxyisobutyric aciduria	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00524	Isovaleric acidemia	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00523	Isobutyryl-coa dehydrogenase deficiency	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00237	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00238	Isovaleric Aciduria	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00422	Imipramine Action Pathway	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00199	Maple Syrup Urine Disease	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00521	3-hydroxyisobutyric acid dehydrogenase deficiency	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00236	Propionic Acidemia	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00200	Methylmalonic Aciduria	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00384	Methylmalonate Semialdehyde Dehydrogenase Deficiency	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00140	3-Methylglutaconic Aciduria Type III	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00139	3-Methylglutaconic Aciduria Type I	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00032	Valine- Leucine and Isoleucine Degradation	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00173	Beta-Ketothiolase Deficiency	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00141	3-Methylglutaconic Aciduria Type IV	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00137	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00138	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	0.353645534180153	-1.03946018337528	30	4	0.0408163265306122	98	978	217,36,64087,316	ALDH2,ACADSB,MCCC2,AOX1
SMP00426	Fluoxetine Action Pathway	0.377674049744712	-0.973723757621678	31	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00467	Trehalose Degradation	0.380163688664672	-0.967153359368132	13	2	0.0204081632653061	98	978	476,481	ATP1A1,ATP1B1
SMP00408	Methadone Action Pathway	0.401636413491197	-0.912208043671172	32	4	0.0408163265306122	98	978	476,481,2902,9254	ATP1A1,ATP1B1,GRIN1,CACNA2D2
SMP00219	UMP Synthase Deiciency (Orotic Aciduria)	0.410041411108903	-0.891497121679573	23	3	0.0306122448979592	98	978	1890,129607,978	TYMP,CMPK2,CDA
SMP00202	MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)	0.410041411108903	-0.891497121679573	23	3	0.0306122448979592	98	978	1890,129607,978	TYMP,CMPK2,CDA
SMP00172	Beta Ureidopropionase Deficiency	0.410041411108903	-0.891497121679573	23	3	0.0306122448979592	98	978	1890,129607,978	TYMP,CMPK2,CDA
SMP00046	Pyrimidine Metabolism	0.410041411108903	-0.891497121679573	23	3	0.0306122448979592	98	978	1890,129607,978	TYMP,CMPK2,CDA
SMP00178	Dihydropyrimidinase Deficiency	0.410041411108903	-0.891497121679573	23	3	0.0306122448979592	98	978	1890,129607,978	TYMP,CMPK2,CDA
SMP00070	Riboflavin Metabolism	0.410853972158837	-0.889517426503114	5	1	0.0102040816326531	98	978	5167	ENPP1
SMP00021	Taurine and Hypotaurine Metabolism	0.410853972158837	-0.889517426503114	5	1	0.0102040816326531	98	978	2571	GAD1
SMP00454	Repaglinide Action Pathway	0.410853972158837	-0.889517426503114	5	1	0.0102040816326531	98	978	9254	CACNA2D2
SMP00453	Nateglinide Action Pathway	0.410853972158837	-0.889517426503114	5	1	0.0102040816326531	98	978	9254	CACNA2D2
SMP00460	Glibenclamide Action Pathway	0.410853972158837	-0.889517426503114	5	1	0.0102040816326531	98	978	9254	CACNA2D2
SMP00018	Alpha Linolenic Acid and Linoleic Acid Metabolism	0.410853972158837	-0.889517426503114	5	1	0.0102040816326531	98	978	9415	FADS2
SMP00643	Pancreas Function	0.410853972158837	-0.889517426503114	5	1	0.0102040816326531	98	978	9254	CACNA2D2
SMP00503	Hypophosphatasia	0.410853972158837	-0.889517426503114	5	1	0.0102040816326531	98	978	316	AOX1
SMP00017	Vitamin B6 Metabolism	0.410853972158837	-0.889517426503114	5	1	0.0102040816326531	98	978	316	AOX1
SMP00569	Succinyl CoA: 3-ketoacid CoA transferase deficiency	0.410853972158837	-0.889517426503114	5	1	0.0102040816326531	98	978	622	BDH1
SMP00071	Ketone Body Metabolism	0.410853972158837	-0.889517426503114	5	1	0.0102040816326531	98	978	622	BDH1
SMP00310	Corticotropin Activation of Cortisol Production	0.410853972158837	-0.889517426503114	5	1	0.0102040816326531	98	978	2778	GNAS
SMP00461	Gliclazide Action Pathway	0.410853972158837	-0.889517426503114	5	1	0.0102040816326531	98	978	9254	CACNA2D2
SMP00429	Disulfiram Action Pathway	0.438127786496754	-0.825244661163855	24	3	0.0306122448979592	98	978	2805,217,2184	GOT1,ALDH2,FAH
SMP00078	Chlorothiazide Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00088	Bumetanide Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00115	Furosemide Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00105	Metolazone Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00197	Lysinuric Protein Intolerance	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00245	Glucose Transporter Defect (SGLT2)	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00090	Bendroflumethiazide Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00100	Hydrochlorothiazide Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00583	Blue diaper syndrome	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00135	Eplerenone Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00483	Kidney Function	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00081	Methyclothiazide Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00108	Hydroflumethiazide Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00723	Cystinuria	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00134	Spironolactone Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00118	Torsemide Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00189	Hartnup Disorder	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00133	Amiloride Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00184	Glucose Transporter Defect (SGLT2)	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00097	Ethacrynic Acid Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00091	Quinethazone Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00585	Lysinuric protein intolerance (LPI)	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00132	Triamterene Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00103	Cyclothiazide Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00110	Indapamide Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00193	Iminoglycinuria	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00121	Trichlormethiazide Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00080	Polythiazide Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00122	Chlorthalidone Action Pathway	0.44903988745625	-0.800643558980129	34	4	0.0408163265306122	98	978	476,481,6337,4306	ATP1A1,ATP1B1,SCNN1A,NR3C2
SMP00345	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	0.453154223934207	-0.791522761253231	15	2	0.0204081632653061	98	978	2235,2990	FECH,GUSB
SMP00494	Tyrosinemia- transient	0.453154223934207	-0.791522761253231	15	2	0.0204081632653061	98	978	2805,2184	GOT1,FAH
SMP00609	Mercaptopurine Metabolism Pathway	0.453154223934207	-0.791522761253231	15	2	0.0204081632653061	98	978	7498,316	XDH,AOX1
SMP00344	Acute Intermittent Porphyria	0.453154223934207	-0.791522761253231	15	2	0.0204081632653061	98	978	2235,2990	FECH,GUSB
SMP00024	Porphyrin Metabolism	0.453154223934207	-0.791522761253231	15	2	0.0204081632653061	98	978	2235,2990	FECH,GUSB
SMP00342	Hereditary Coproporphyria (HCP)	0.453154223934207	-0.791522761253231	15	2	0.0204081632653061	98	978	2235,2990	FECH,GUSB
SMP00346	Porphyria Variegata (PV)	0.453154223934207	-0.791522761253231	15	2	0.0204081632653061	98	978	2235,2990	FECH,GUSB
SMP00636	Venlafaxine Metabolism Pathway	0.47019242100734	-0.754613261663369	6	1	0.0102040816326531	98	978	5243	ABCB1
SMP00343	Intracellular Signalling Through PGD2 receptor and Prostaglandin D2	0.47019242100734	-0.754613261663369	6	1	0.0102040816326531	98	978	2778	GNAS
SMP00628	Nicotine Metabolism Pathway	0.47019242100734	-0.754613261663369	6	1	0.0102040816326531	98	978	316	AOX1
SMP00308	Dopamine Activation of Neurological Reward System	0.47019242100734	-0.754613261663369	6	1	0.0102040816326531	98	978	2778	GNAS
SMP00336	Vitamin A Deficiency	0.47233606602386	-0.750064542463543	35	4	0.0408163265306122	98	978	51726,10130,10961,9601	DNAJB11,PDIA6,ERP29,PDIA4
SMP00074	Retinol Metabolism	0.47233606602386	-0.750064542463543	35	4	0.0408163265306122	98	978	51726,10130,10961,9601	DNAJB11,PDIA6,ERP29,PDIA4
SMP00652	Mycophenolic Acid Metabolism Pathway	0.487816318707429	-0.717816340075113	16	2	0.0204081632653061	98	978	5243,9429	ABCB1,ABCG2
SMP00004	Glycine and Serine Metabolism	0.492714596808084	-0.707825183712989	26	3	0.0306122448979592	98	978	217,1491,63826	ALDH2,CTH,SRR
SMP00484	Dimethylglycine Dehydrogenase Deficiency	0.492714596808084	-0.707825183712989	26	3	0.0306122448979592	98	978	217,1491,63826	ALDH2,CTH,SRR
SMP00244	Sarcosinemia	0.492714596808084	-0.707825183712989	26	3	0.0306122448979592	98	978	217,1491,63826	ALDH2,CTH,SRR
SMP00242	Dimethylglycine Dehydrogenase Deficiency	0.492714596808084	-0.707825183712989	26	3	0.0306122448979592	98	978	217,1491,63826	ALDH2,CTH,SRR
SMP00223	Non Ketotic Hyperglycinemia	0.492714596808084	-0.707825183712989	26	3	0.0306122448979592	98	978	217,1491,63826	ALDH2,CTH,SRR
SMP00179	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	0.492714596808084	-0.707825183712989	26	3	0.0306122448979592	98	978	217,1491,63826	ALDH2,CTH,SRR
SMP00721	3-Phosphoglycerate dehydrogenase deficiency	0.492714596808084	-0.707825183712989	26	3	0.0306122448979592	98	978	217,1491,63826	ALDH2,CTH,SRR
SMP00485	Hyperglycinemia- non-ketotic	0.492714596808084	-0.707825183712989	26	3	0.0306122448979592	98	978	217,1491,63826	ALDH2,CTH,SRR
SMP00218	Tyrosinemia Type I	0.521099616362209	-0.65181405327486	17	2	0.0204081632653061	98	978	2805,2184	GOT1,FAH
SMP00498	Dopamine beta-hydroxylase deficiency	0.521099616362209	-0.65181405327486	17	2	0.0204081632653061	98	978	2805,2184	GOT1,FAH
SMP00533	Monoamine oxidase-a deficiency (MAO-A)	0.521099616362209	-0.65181405327486	17	2	0.0204081632653061	98	978	2805,2184	GOT1,FAH
SMP00190	Hawkinsinuria	0.521099616362209	-0.65181405327486	17	2	0.0204081632653061	98	978	2805,2184	GOT1,FAH
SMP00006	Tyrosine Metabolism	0.521099616362209	-0.65181405327486	17	2	0.0204081632653061	98	978	2805,2184	GOT1,FAH
SMP00169	Alkaptonuria	0.521099616362209	-0.65181405327486	17	2	0.0204081632653061	98	978	2805,2184	GOT1,FAH
SMP00449	Ethanol Degradation	0.523609234528036	-0.64700960849375	7	1	0.0102040816326531	98	978	217	ALDH2
SMP00322	Vasopressin Regulation of Water Homeostasis	0.523609234528036	-0.64700960849375	7	1	0.0102040816326531	98	978	2778	GNAS
SMP00627	Citalopram Metabolism Pathway	0.523609234528036	-0.64700960849375	7	1	0.0102040816326531	98	978	316	AOX1
SMP00706	Tenoxicam Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00693	Antrafenine Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00102	Bromfenac Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00699	Lumiracoxib Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00098	Ketorolac Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00106	Meloxicam Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00707	Salsalate Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00085	Ketoprofen Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00692	Antipyrine Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00353	Leukotriene C4 Synthesis Deficiency	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00700	Lornoxicam Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00701	Phenylbutazone Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00094	Sulindac Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00114	Nabumetone Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00109	Mefenamic Acid Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00113	Oxaprozin Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00702	Nepafenac Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00698	Magnesium salicylate Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00289	Diflunisal Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00708	Salicylate-sodium Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00077	Piroxicam Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00083	Acetylsalicylic Acid Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00710	Acetaminophen  Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00697	Flurbiprofen Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00084	Etodolac Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00075	Arachidonic Acid Metabolism	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00696	Fenoprofen Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00703	Trisalicylate-choline Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00709	Salicylic Acid Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00093	Diclofenac Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00695	Etoricoxib Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00101	Suprofen Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00704	Tolmetin Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00694	Carprofen Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00705	Tiaprofenic Acid Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00087	Rofecoxib Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00116	Valdecoxib Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00120	Naproxen Action Pathway	0.544639238226327	-0.607631651711913	28	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00104	Indomethacin Action Pathway	0.569446897126296	-0.563089745172405	29	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00487	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	0.571689867913169	-0.559158623602916	8	1	0.0102040816326531	98	978	6697	SPR
SMP00496	Galactosemia III	0.571689867913169	-0.559158623602916	8	1	0.0102040816326531	98	978	5236	PGM1
SMP00030	Oxidation of Branched Chain Fatty Acids	0.571689867913169	-0.559158623602916	8	1	0.0102040816326531	98	978	217	ALDH2
SMP00005	Pterine Biosynthesis	0.571689867913169	-0.559158623602916	8	1	0.0102040816326531	98	978	6697	SPR
SMP00488	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	0.571689867913169	-0.559158623602916	8	1	0.0102040816326531	98	978	6697	SPR
SMP00495	Galactosemia II (GALK)	0.571689867913169	-0.559158623602916	8	1	0.0102040816326531	98	978	5236	PGM1
SMP00010	Nucleotide Sugars Metabolism	0.571689867913169	-0.559158623602916	8	1	0.0102040816326531	98	978	5236	PGM1
SMP00028	Caffeine Metabolism	0.571689867913169	-0.559158623602916	8	1	0.0102040816326531	98	978	7498	XDH
SMP00490	Segawa syndrome	0.571689867913169	-0.559158623602916	8	1	0.0102040816326531	98	978	6697	SPR
SMP00491	Sepiapterin reductase deficiency	0.571689867913169	-0.559158623602916	8	1	0.0102040816326531	98	978	6697	SPR
SMP00486	Dopa-responsive dystonia	0.571689867913169	-0.559158623602916	8	1	0.0102040816326531	98	978	6697	SPR
SMP00489	Hyperphenylalaninemia due to dhpr-deficiency	0.571689867913169	-0.559158623602916	8	1	0.0102040816326531	98	978	6697	SPR
SMP00354	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	0.571689867913169	-0.559158623602916	8	1	0.0102040816326531	98	978	2778	GNAS
SMP00340	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.58326336129397	-0.539116459994992	19	2	0.0204081632653061	98	978	191,1491	AHCY,CTH
SMP00214	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	0.58326336129397	-0.539116459994992	19	2	0.0204081632653061	98	978	191,1491	AHCY,CTH
SMP00221	Methionine Adenosyltransferase Deficiency	0.58326336129397	-0.539116459994992	19	2	0.0204081632653061	98	978	191,1491	AHCY,CTH
SMP00177	Cystathionine Beta-Synthase Deficiency	0.58326336129397	-0.539116459994992	19	2	0.0204081632653061	98	978	191,1491	AHCY,CTH
SMP00341	Hypermethioninemia	0.58326336129397	-0.539116459994992	19	2	0.0204081632653061	98	978	191,1491	AHCY,CTH
SMP00033	Methionine Metabolism	0.58326336129397	-0.539116459994992	19	2	0.0204081632653061	98	978	191,1491	AHCY,CTH
SMP00222	Glycine N-methyltransferase Deficiency	0.58326336129397	-0.539116459994992	19	2	0.0204081632653061	98	978	191,1491	AHCY,CTH
SMP00570	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism- cblG complementation type	0.58326336129397	-0.539116459994992	19	2	0.0204081632653061	98	978	191,1491	AHCY,CTH
SMP00335	Intracellular Signalling Through Histamine H2 Receptor and Histamine	0.614962437960623	-0.486194089527656	9	1	0.0102040816326531	98	978	2778	GNAS
SMP00610	Clopidogrel Metabolism Pathway	0.614962437960623	-0.486194089527656	9	1	0.0102040816326531	98	978	5243	ABCB1
SMP00716	Thyroid hormone synthesis	0.614962437960623	-0.486194089527656	9	1	0.0102040816326531	98	978	53905	DUOX1
SMP00333	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	0.614962437960623	-0.486194089527656	9	1	0.0102040816326531	98	978	2778	GNAS
SMP00260	Clopidogrel Action Pathway	0.614962437960623	-0.486194089527656	9	1	0.0102040816326531	98	978	5243	ABCB1
SMP00312	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	0.614962437960623	-0.486194089527656	9	1	0.0102040816326531	98	978	2778	GNAS
SMP00309	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	0.614962437960623	-0.486194089527656	9	1	0.0102040816326531	98	978	2778	GNAS
SMP00311	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	0.614962437960623	-0.486194089527656	9	1	0.0102040816326531	98	978	2778	GNAS
SMP00624	Methadone Metabolism Pathway	0.653903285309702	-0.424795820249975	10	1	0.0102040816326531	98	978	2902	GRIN1
SMP00338	Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin	0.653903285309702	-0.424795820249975	10	1	0.0102040816326531	98	978	2778	GNAS
SMP00128	Gluconeogenesis	0.665146600593924	-0.40774781060132	22	2	0.0204081632653061	98	978	5236,53354	PGM1,PANK1
SMP00581	Glycogenosis- Type IA. Von gierke disease	0.665146600593924	-0.40774781060132	22	2	0.0204081632653061	98	978	5236,53354	PGM1,PANK1
SMP00574	Glycogenosis- Type IC	0.665146600593924	-0.40774781060132	22	2	0.0204081632653061	98	978	5236,53354	PGM1,PANK1
SMP00563	Triosephosphate isomerase	0.665146600593924	-0.40774781060132	22	2	0.0204081632653061	98	978	5236,53354	PGM1,PANK1
SMP00562	Fructose-1-6-diphosphatase deficiency	0.665146600593924	-0.40774781060132	22	2	0.0204081632653061	98	978	5236,53354	PGM1,PANK1
SMP00374	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	0.665146600593924	-0.40774781060132	22	2	0.0204081632653061	98	978	5236,53354	PGM1,PANK1
SMP00560	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	0.665146600593924	-0.40774781060132	22	2	0.0204081632653061	98	978	5236,53354	PGM1,PANK1
SMP00573	Glycogenosis- Type IB	0.665146600593924	-0.40774781060132	22	2	0.0204081632653061	98	978	5236,53354	PGM1,PANK1
SMP00096	Celecoxib Action Pathway	0.68053033554025	-0.384882879573766	34	3	0.0306122448979592	98	978	113612,4048,4051	CYP2U1,LTA4H,CYP4F3
SMP00635	Valproic Acid Metabolism Pathway	0.688942002294122	-0.372598188152864	11	1	0.0102040816326531	98	978	36	ACADSB
SMP00391	Insulin Signalling	0.688942002294122	-0.372598188152864	11	1	0.0102040816326531	98	978	207	AKT1
SMP00009	Ammonia Recycling	0.688942002294122	-0.372598188152864	11	1	0.0102040816326531	98	978	3034	HAL
SMP00543	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.720465977244264	-0.327857085692534	12	1	0.0102040816326531	98	978	8836	GGH
SMP00053	Folate Metabolism	0.720465977244264	-0.327857085692534	12	1	0.0102040816326531	98	978	8836	GGH
SMP00432	Methotrexate Action Pathway	0.720465977244264	-0.327857085692534	12	1	0.0102040816326531	98	978	8836	GGH
SMP00068	Androgen and Estrogen Metabolism	0.720465977244264	-0.327857085692534	12	1	0.0102040816326531	98	978	6820	SULT2B1
SMP00565	Aromatase deficiency	0.720465977244264	-0.327857085692534	12	1	0.0102040816326531	98	978	6820	SULT2B1
SMP00724	Folate malabsorption- hereditary	0.720465977244264	-0.327857085692534	12	1	0.0102040816326531	98	978	8836	GGH
SMP00356	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	0.720465977244264	-0.327857085692534	12	1	0.0102040816326531	98	978	6820	SULT2B1
SMP00603	Gemcitabine Metabolism Pathway	0.748824501294788	-0.289250633607822	13	1	0.0102040816326531	98	978	1633	DCK
SMP00446	Gemcitabine Action Pathway	0.748824501294788	-0.289250633607822	13	1	0.0102040816326531	98	978	1633	DCK
SMP00025	Phospholipid Biosynthesis	0.753814854899455	-0.282608491657876	26	2	0.0204081632653061	98	978	51573,1040	GDE1,CDS1
SMP00282	Streptokinase Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00185	Glutaric Aciduria Type I	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	36	ACADSB
SMP00268	Warfarin Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00276	Argatroban Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00288	Aprotinin Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00540	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	36	ACADSB
SMP00279	Ximelagatran Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00281	Anistreplase Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00545	Trifunctional protein deficiency	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	36	ACADSB
SMP00656	Dicoumarol Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00283	Tenecteplase Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00542	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	36	ACADSB
SMP00269	Acenocoumarol Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00280	Alteplase Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00277	Bivalirudin Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00271	Phenprocoumon Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00235	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	36	ACADSB
SMP00285	Reteplase Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00278	Lepirudin Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00181	Ethylmalonic Encephalopathy	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	36	ACADSB
SMP00655	Phenindione Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00586	Coagulation 	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00284	Urokinase Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00287	Tranexamic Acid Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00067	Aspartate Metabolism	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2571	GAD1
SMP00538	Carnitine palmitoyl transferase deficiency (I)	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	36	ACADSB
SMP00270	Dicumarol Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00541	Carnitine palmitoyl transferase deficiency (II)	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	36	ACADSB
SMP00175	Canavan Disease	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2571	GAD1
SMP00192	Hypoacetylaspartia	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2571	GAD1
SMP00051	Fatty acid Metabolism	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	36	ACADSB
SMP00286	Aminocaproic Acid Action Pathway	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	2161	F12
SMP00539	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	0.774332479402728	-0.255753937675028	14	1	0.0102040816326531	98	978	36	ACADSB
SMP00275	Ardeparin Action Pathway	0.797273783366295	-0.226557141782403	15	1	0.0102040816326531	98	978	2161	F12
SMP00518	Glucose-6-phosphate dehydrogenase deficiency	0.797273783366295	-0.226557141782403	15	1	0.0102040816326531	98	978	5236	PGM1
SMP00031	Pentose Phosphate Pathway	0.797273783366295	-0.226557141782403	15	1	0.0102040816326531	98	978	5236	PGM1
SMP00273	Fondaparinux Action Pathway	0.797273783366295	-0.226557141782403	15	1	0.0102040816326531	98	978	2161	F12
SMP00040	Glycolysis	0.797273783366295	-0.226557141782403	15	1	0.0102040816326531	98	978	53354	PANK1
SMP00274	Heparin Action Pathway	0.797273783366295	-0.226557141782403	15	1	0.0102040816326531	98	978	2161	F12
SMP00531	Glycogenosis- Type VII. Tarui disease	0.797273783366295	-0.226557141782403	15	1	0.0102040816326531	98	978	53354	PANK1
SMP00272	Enoxaparin Action Pathway	0.797273783366295	-0.226557141782403	15	1	0.0102040816326531	98	978	2161	F12
SMP00519	Ribose-5-phosphate isomerase deficiency	0.797273783366295	-0.226557141782403	15	1	0.0102040816326531	98	978	5236	PGM1
SMP00520	Transaldolase deficiency	0.797273783366295	-0.226557141782403	15	1	0.0102040816326531	98	978	5236	PGM1
SMP00572	Fanconi-bickel syndrome	0.797273783366295	-0.226557141782403	15	1	0.0102040816326531	98	978	53354	PANK1
SMP00317	Familial Hypercholanemia (FHCA)	0.836454572553147	-0.178583066601166	17	1	0.0102040816326531	98	978	8309	ACOX2
SMP00316	Zellweger Syndrome	0.836454572553147	-0.178583066601166	17	1	0.0102040816326531	98	978	8309	ACOX2
SMP00315	Cerebrotendinous Xanthomatosis (CTX)	0.836454572553147	-0.178583066601166	17	1	0.0102040816326531	98	978	8309	ACOX2
SMP00314	Congenital Bile Acid Synthesis Defect Type II	0.836454572553147	-0.178583066601166	17	1	0.0102040816326531	98	978	8309	ACOX2
SMP00035	Bile Acid Biosynthesis	0.836454572553147	-0.178583066601166	17	1	0.0102040816326531	98	978	8309	ACOX2
SMP00318	Congenital Bile Acid Synthesis Defect Type III	0.836454572553147	-0.178583066601166	17	1	0.0102040816326531	98	978	8309	ACOX2
SMP00720	27-Hydroxylase Deficiency	0.836454572553147	-0.178583066601166	17	1	0.0102040816326531	98	978	8309	ACOX2
SMP00428	Mercaptopurine Action Pathway	0.868964036918168	-0.1404535390171	47	3	0.0306122448979592	98	978	5144,7498,316	PDE4D,XDH,AOX1
SMP00430	Thioguanine Action Pathway	0.868964036918168	-0.1404535390171	47	3	0.0306122448979592	98	978	5144,7498,316	PDE4D,XDH,AOX1
SMP00427	Azathioprine Action Pathway	0.868964036918168	-0.1404535390171	47	3	0.0306122448979592	98	978	5144,7498,316	PDE4D,XDH,AOX1
SMP00203	Molybdenum Cofactor Deficiency	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00167	Adenylosuccinate Lyase Deficiency	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00365	Gout or Kelley-Seegmiller Syndrome	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00220	Xanthine Dehydrogenase Deficiency (Xanthinuria)	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00537	Myoadenylate deaminase deficiency	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00050	Purine Metabolism	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00144	Adenosine Deaminase Deficiency	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00536	Mitochondrial DNA depletion syndrome	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00535	Adenine phosphoribosyltransferase deficiency (APRT)	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00512	Xanthinuria type I	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00513	Xanthinuria type II	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00210	Purine Nucleoside Phosphorylase Deficiency	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00364	Lesch-Nyhan Syndrome (LNS)	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00168	AICA-Ribosiduria	0.901494743616908	-0.103701067063576	37	2	0.0204081632653061	98	978	5144,7498	PDE4D,XDH
SMP00060	Pyruvate Metabolism	0.904597323366072	-0.10026538085713	22	1	0.0102040816326531	98	978	217	ALDH2
SMP00334	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	0.904597323366072	-0.10026538085713	22	1	0.0102040816326531	98	978	217	ALDH2
SMP00196	Leigh Syndrome	0.904597323366072	-0.10026538085713	22	1	0.0102040816326531	98	978	217	ALDH2
SMP00212	Pyruvate Dehydrogenase Complex Deficiency	0.904597323366072	-0.10026538085713	22	1	0.0102040816326531	98	978	217	ALDH2
SMP00558	Primary hyperoxaluria II- PH2	0.904597323366072	-0.10026538085713	22	1	0.0102040816326531	98	978	217	ALDH2
SMP00559	Pyruvate kinase deficiency	0.904597323366072	-0.10026538085713	22	1	0.0102040816326531	98	978	217	ALDH2
SMP00654	Warburg Effect	0.992310693791617	-0.00771902134724264	45	1	0.0102040816326531	98	978	3417	IDH1
SMP00612	Esomeprazole Metabolism Pathway	0.999999999996841	-3.1590303289919e-12	2	0	0	98	978
SMP00616	Rabeprazole Metabolism Pathway	0.999999999996841	-3.1590303289919e-12	2	0	0	98	978
SMP00613	Omeprazole Metabolism Pathway	0.999999999996841	-3.1590303289919e-12	2	0	0	98	978
SMP00614	Lansoprazole Metabolism Pathway	0.999999999996841	-3.1590303289919e-12	2	0	0	98	978
SMP00615	Pantoprazole Metabolism Pathway	0.999999999996841	-3.1590303289919e-12	2	0	0	98	978
SMP00456	Fatty Acid Biosynthesis	0.999999999996841	-3.1590303289919e-12	2	0	0	98	978
SMP00420	Bevacizumab Action Pathway	0.999999999999418	-5.81674899219342e-13	3	0	0	98	978
SMP00653	Rosiglitazone Metabolism Pathway	0.999999999999418	-5.81674899219342e-13	3	0	0	98	978
SMP00126	Phenylacetate Metabolism	0.999999999999418	-5.81674899219342e-13	3	0	0	98	978
SMP00564	Multiple carboxylase deficiency- neonatal or early onset form	0.999999999999418	-5.81674899219342e-13	3	0	0	98	978
SMP00626	Desipramine Metabolism Pathway	0.999999999999418	-5.81674899219342e-13	3	0	0	98	978
SMP00124	Glycerol Phosphate Shuttle	0.999999999999418	-5.81674899219342e-13	3	0	0	98	978
SMP00459	Pyruvaldehyde Degradation	0.999999999999418	-5.81674899219342e-13	3	0	0	98	978
SMP00174	Biotinidase Deficiency	0.999999999999418	-5.81674899219342e-13	3	0	0	98	978
SMP00066	Biotin Metabolism	0.999999999999418	-5.81674899219342e-13	3	0	0	98	978
SMP00631	Prednisone Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00265	Abciximab Action Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00476	Trastuzumab Action Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00593	Enalapril Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00732	Temocapril Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00632	Prednisolone Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00473	Gefitinib Action Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00261	Ticlopidine Action Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00595	Moexipril Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00475	Panitumumab Action Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00647	Thioguanine Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00474	Cetuximab Action Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00591	Benazepril Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00597	Ramipril Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00267	Tirofiban Action Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00596	Quinapril Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00617	Cimetidine Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00421	Vatalanib Action Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00592	Cilazapril Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00036	D-Arginine and D-Ornithine Metabolism	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00470	Fluorouracil Action Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00611	Ticlopidine Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00599	Trandolapril Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00594	Fosinopril Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00598	Spirapril Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00440	Prednisone Action Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00638	Levomethadyl Acetate Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00441	Prednisolone Action Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00266	Eptifibatide Action Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00608	Fluorouracil Metabolism Pathway	0.999999999999612	-3.87925802591838e-13	1	0	0	98	978
SMP00153	Quinapril Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00623	Heroin Metabolism Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00165	Valsartan Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00602	Teniposide Metabolism Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00150	Lisinopril Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00633	Felbamate Metabolism Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00164	Telmisartan Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00076	Thiamine Metabolism	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00651	Artemether Metabolism Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00170	Aromatic L-Aminoacid Decarboxylase Deficiency	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00145	Benazepril Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00620	Lidocaine (Local Anaesthetic) Metabolism Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00443	Teniposide Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00733	Temocapril Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00621	Codeine Metabolism Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00152	Perindopril Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00012	Catecholamine Biosynthesis	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00149	Fosinopril Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00065	Ubiquinone Biosynthesis	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00163	Olmesartan Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00629	Adefovir Dipivoxil Metabolism Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00154	Ramipril Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00497	Tyrosine hydroxylase deficiency	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00479	Plasmalogen Synthesis	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00148	Enalapril Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00162	Losartan Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00155	Rescinnamine Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00161	Irbesartan Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00639	Clomipramine Metabolism Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00146	Captopril Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00160	Forasartan Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00129	Malate-Aspartate Shuttle	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00587	Angiotensin Metabolism	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00159	Eprosartan Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00147	Cilazapril Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00630	Tenofovir Metabolism Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00156	Spirapril Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00151	Moexipril Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00158	Candesartan Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00157	Trandolapril Action Pathway	1.00000000000011	1.11798320167472e-13	4	0	0	98	978
SMP00055	Alanine Metabolism	1.00000000000094	9.427825612752e-13	5	0	0	98	978
SMP00468	Degradation of Superoxides	1.00000000000094	9.427825612752e-13	5	0	0	98	978
SMP00352	Primary Hyperoxaluria Type I	1.00000000000094	9.427825612752e-13	5	0	0	98	978
SMP00516	Adrenoleukodystrophy- X-linked	1.00000000000094	9.427825612752e-13	5	0	0	98	978
SMP00350	Pyruvate Carboxylase Deficiency	1.00000000000094	9.427825612752e-13	5	0	0	98	978
SMP00641	Doxepin Metabolism Pathway	1.00000000000094	9.427825612752e-13	5	0	0	98	978
SMP00052	Beta Oxidation of Very Long Chain Fatty Acids	1.00000000000094	9.427825612752e-13	5	0	0	98	978
SMP00313	Lactic Acidemia	1.00000000000094	9.427825612752e-13	5	0	0	98	978
SMP00517	Carnitine-acylcarnitine translocase deficiency	1.00000000000094	9.427825612752e-13	5	0	0	98	978
SMP00465	Carnitine Synthesis	1.00000000000094	9.427825612752e-13	5	0	0	98	978
SMP00646	Fluoxetine Metabolism Pathway	1.00000000000218	2.18043113581963e-12	6	0	0	98	978
SMP00445	Spermidine and Spermine Biosynthesis	1.00000000000218	2.18043113581963e-12	6	0	0	98	978
SMP00478	Nucleotide Excision Repair 	1.00000000000218	2.18043113581963e-12	6	0	0	98	978
SMP00625	Imipramine Metabolism Pathway	1.00000000000218	2.18043113581963e-12	6	0	0	98	978
SMP00054	Fatty Acid Elongation In Mitochondria	1.00000000000233	2.33136864084716e-12	7	0	0	98	978
SMP00634	Carbamazepine Metabolism Pathway	1.00000000000233	2.33136864084716e-12	7	0	0	98	978
SMP00544	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	1.00000000000233	2.33136864084716e-12	7	0	0	98	978
SMP00637	Tramadol Metabolism Pathway	1.00000000000233	2.33136864084716e-12	7	0	0	98	978
SMP00605	Ifosfamide Metabolism Pathway	1.00000000000297	2.97296365414521e-12	8	0	0	98	978
SMP00481	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	1.00000000000297	2.97296365414521e-12	8	0	0	98	978
SMP00127	Glucose-Alanine Cycle	1.00000000000297	2.97296365414521e-12	8	0	0	98	978
SMP00073	Butyrate Metabolism	1.00000000000297	2.97296365414521e-12	8	0	0	98	978
SMP00480	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	1.00000000000297	2.97296365414521e-12	8	0	0	98	978
SMP00448	Ifosfamide Action Pathway	1.00000000000297	2.97296365414521e-12	8	0	0	98	978
SMP00568	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	1.00000000000297	2.97296365414521e-12	8	0	0	98	978
SMP00644	Celecoxib Metabolism Pathway	1.00000000000297	2.97296365414521e-12	8	0	0	98	978
SMP00642	Nevirapine Metabolism Pathway	1.00000000000297	2.97296365414521e-12	8	0	0	98	978
SMP00228	Pantoprazole Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00580	GLUT-1 deficiency syndrome	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00232	Cimetidine Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00444	Lactose Synthesis	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00225	Esomeprazole Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00604	Cyclophosphamide Metabolism Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00230	Ranitidine Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00734	Roxatidine acetate Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00226	Omeprazole Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00735	Metiamide Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00452	Threonine and 2-Oxobutanoate Degradation	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00736	Betazole Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00589	Gastric Acid Production	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00229	Rabeprazole Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00233	Nizatidine Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00466	Transfer of Acetyl Groups into Mitochondria	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00227	Lansoprazole Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00231	Famotidine Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00246	Pirenzepine Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00579	Congenital disorder of glycosylation CDG-IId	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00447	Cyclophosphamide Action Pathway	1.00000000000387	3.86893539428166e-12	9	0	0	98	978
SMP00482	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	1.00000000000514	5.13766045351733e-12	10	0	0	98	978
SMP00606	Tamoxifen Metabolism Pathway	1.00000000000514	5.13766045351733e-12	10	0	0	98	978
SMP00471	Tamoxifen Action Pathway	1.00000000000514	5.13766045351733e-12	10	0	0	98	978
SMP00566	17-alpha-hydroxylase deficiency (CYP17)	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00371	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00575	11-beta-hydroxylase deficiency (CYP11B1)	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00187	Glycerol Kinase Deficiency	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00717	Apparent mineralocorticoid excess syndrome	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00372	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00576	21-hydroxylase deficiency (CYP21)	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00577	Corticosterone methyl oxidase I deficiency (CMO I)	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00578	Corticosterone methyl oxidase II deficiency - CMO II	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00530	Familial lipoprotein lipase deficiency	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00529	D-glyceric acidura	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00718	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00039	Glycerolipid Metabolism	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00373	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00130	Steroidogenesis	1.00000000000612	6.11591766428952e-12	11	0	0	98	978
SMP00002	Carbamoyl Phosphate Synthetase Deficiency	1.00000000000936	9.35939759445188e-12	13	0	0	98	978
SMP00003	Argininosuccinic Aciduria	1.00000000000936	9.35939759445188e-12	13	0	0	98	978
SMP00205	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	1.00000000000936	9.35939759445188e-12	13	0	0	98	978
SMP00357	Argininemia	1.00000000000936	9.35939759445188e-12	13	0	0	98	978
SMP00001	Citrullinemia Type I	1.00000000000936	9.35939759445188e-12	13	0	0	98	978
SMP00059	Urea Cycle	1.00000000000936	9.35939759445188e-12	13	0	0	98	978
SMP00198	Malonic Aciduria	1.00000000000937	9.36722316006451e-12	14	0	0	98	978
SMP00201	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	1.00000000000937	9.36722316006451e-12	14	0	0	98	978
SMP00502	Malonyl-coa decarboxylase deficiency	1.00000000000937	9.36722316006451e-12	14	0	0	98	978
SMP00016	Propanoate Metabolism	1.00000000000937	9.36722316006451e-12	14	0	0	98	978
SMP00725	Fructose intolerance- hereditary	1.00000000001461	1.46145449391601e-11	18	0	0	98	978
SMP00561	Fructosuria	1.00000000001461	1.46145449391601e-11	18	0	0	98	978
SMP00064	Fructose and Mannose Degradation	1.00000000001461	1.46145449391601e-11	18	0	0	98	978
SMP00355	Mitochondrial Electron Transport Chain	1.00000000001513	1.51296946147127e-11	19	0	0	98	978
SMP00092	Rosuvastatin Action Pathway	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00508	Cholesteryl ester storage disease	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00510	Mevalonic aciduria	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00387	CHILD Syndrome	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00095	Alendronate Action Pathway	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00107	Zoledronate Action Pathway	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00548	Mitochondrial complex II deficiency	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00389	Smith-Lemli-Opitz Syndrome (SLOS)	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00112	Risedronate Action Pathway	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00119	Fluvastatin Action Pathway	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00079	Ibandronate Action Pathway	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00057	Citric Acid Cycle	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00209	Hypercholesterolemia	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00388	Chondrodysplasia Punctata II- X Linked Dominant (CDPX2)	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00386	Desmosterolosis	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00551	Pyruvate dehydrogenase deficiency (E2)	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00511	Wolman disease	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00023	Steroid Biosynthesis	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00099	Lovastatin Action Pathway	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00509	Hyper-IgD syndrome	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00131	Atorvastatin Action Pathway	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00082	Simvastatin Action Pathway	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00117	Pamidronate Action Pathway	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00546	Congenital lactic acidosis	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00319	Lysosomal Acid Lipase Deficiency (Wolman Disease)	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00111	Cerivastatin Action Pathway	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00549	2-ketoglutarate dehydrogenase complex deficiency	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00547	Fumarase deficiency	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00089	Pravastatin Action Pathway	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
SMP00550	Pyruvate dehydrogenase deficiency (E3)	1.00000000001753	1.75253955101973e-11	21	0	0	98	978
